Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | STK11 |
Variant | K48fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | STK11 K48fs results in a change in the amino acid sequence of the Stk11 protein beginning at aa 48 of 433, likely resulting in premature truncation of the functional protein (UniProt.org). K48fs has not been characterized however, due to the effects of other truncation mutations downstream of K48 (PMID: 23612973), is predicted to lead to a loss of Stk11 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
STK11 mutant STK11 inact mut STK11 K48fs |
Transcript | NM_000455.5 |
gDNA | chr19:g.(1207054_1207055) |
cDNA | c.(142_141) |
Protein | p.K48fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005259617.3 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
XM_005259618.3 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
XM_011528209 | chr19:g.(1218489_1218490) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
NM_000455 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
XM_011528209.2 | chr19:g.(1218489_1218490) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
XM_005259618 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
NM_000455.5 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
NM_001407255.1 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
XM_005259617 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
NM_000455.4 | chr19:g.(1207054_1207055) | c.(142_141) | p.K48fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
STK11 K48fs | lung non-small cell carcinoma | sensitive | Trametinib | Preclinical - Cell culture | Actionable | In a preclinical study, non-small cell lung cancer cell lines harboring STK11 inactivating mutations, such as STK11 K48fs, demonstrated increased sensitivity to Mekinist (trametinib) in culture (PMID: 27821489). | 27821489 |